- A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice Science
- National Institutes of Health Launches Clinical Trial of Epstein-Barr Virus Vaccine SciTechDaily
- Hope for 1st vaccine against virus driving 'mono,’ cancers and maybe MS Medical Xpress
- View Full Coverage on Google News